Goldman Sachs Reinstates Esperion Therapeutics (ESPR) at Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. CME
9. cASY
10. TSLA

Go back to Goldman Sachs Reinstates Esperion Therapeutics (ESPR) at Neutral
ESPERION THERAP (NASDAQ: ESPR) Delayed: 3.15 +0.01 (0.32%)
Previous Close $3.14    52 Week High $30.41 
Open $3.14    52 Week Low $9.40 
Day High $3.15    P/E N/A 
Day Low $3.14    EPS $-21.87 
Volume 7,053,480